VERAX BIOMEDICAL INC — Form D/A

VERAX BIOMEDICAL INC of WORCESTER, MA, a company, filed a Form D amendment with the SEC on 2012-10-25. The offering totals $5.0M, of which $3.3M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (27)

Showing 25 of 27 people.

NameRoleLocation
GREG SCOTT LAWRENCEExecutive OfficerWORCESTER, MA
Robert ZieserlDirectorWORCESTER, MA
Marc GoldbergDirectorWORCESTER, MA
Buzz BensonDirectorWORCESTER, MA
James LousararianDirectorWORCESTER, MA
James LousararianExecutive OfficerWORCESTER, MA
Robert FlanaganDirectorCresskill, NJ
Paul RagusaExecutive OfficerMarlborough, MA
Joe SandersDirectorMarlborough, MA
Joe SandersExecutive OfficerMarlborough, MA
JOE DEL GUERCIODirectorWORCESTER, MA
PAUL REMO RAGUSAExecutive OfficerMARLBOROUGH, MA
JAMES E KOZIARZDirectorMARLBOROUGH, MA
YLI REMO VALLEJOExecutive OfficerMARLBOROUGH, MA
NANCY A HORNBAKERExecutive OfficerMARLBOROUGH, MA
JOE R SANDERSDirectorMARLBOROUGH, MA
JOE R SANDERSExecutive OfficerMARLBOROUGH, MA
R. SCOTT MCKENZIEExecutive OfficerWORCESTER, MA
JAMES KOZIARZDirectorWORCESTER, MA
R. SCOTT MCKENZIE, SR.Executive OfficerMARLBOROUGH, MA
GREGORY SCOTT LAWRENCEExecutive OfficerMARLBOROUGH, MA
PAUL SCOTT RAGUSAExecutive OfficerMARLBOROUGH, MA
Marc E GoldbergDirectorStoughton, MA
JEFFREY A HALLExecutive OfficerWORCESTER, MA
NANCY A. HORNBAKERExecutive OfficerWORCESTER, MA

Other filings by this issuer (10)

FiledFormOfferingSold
2019-09-19D$10.5M$2.5M
2017-11-13D$24.1M$11.4M
2016-06-27D/A$24.5M$12.6M
2016-03-02D$12.6M$12.6M
2015-01-21D$4.0M$4.0M
2013-10-15D/A$11.8M$8.5M
2013-07-31D$11.8M$6.8M
2012-08-14D$5.0M$2.8M
2011-03-22D$1.3M$1.3M
2009-04-15D$10.0M$2.1M

More